Document Detail


Identification of pathways controlling muscle protein metabolism in uremia and other catabolic conditions.
MedLine Citation:
PMID:  15931008     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: Major progress has been made in defining two key steps that mediate muscle protein degradation in kidney disease and other catabolic conditions. These advances are identified and discussed. RECENT FINDINGS: Activation of caspase-3 in muscle was discovered to be the initial step in breaking down the complex structure of myofibrils. Caspase-3 cleaves the complex structure, yielding substrate proteins and protein fragments that are degraded by the ubiquitin-proteasome system. Activation of caspase-3 occurs when insulin receptor substrate-1-associated phosphatidylinositol 3 kinase activity is suppressed in different models of catabolic conditions. The E3 ubiquitin ligases, MAFbx (also called atrogin-1) and MuRF1, were previously shown to play an essential role in muscle wasting. Several reports show that the insulin receptor substrate-1-associated phosphatidylinositol 3 kinase/Akt pathway activates forkhead transcription factors to increase expression of MAFbx/atrogin-1 and MuRF1. This response induces muscle protein wasting. In addition, chronic activation of the transcription factor, nuclear factor-kappaB, induces muscle atrophy. SUMMARY: The insulin-like growth factor-1/insulin receptor substrate-1-associated phosphatidylinositol 3 kinase/Akt cellular signaling pathway coordinately regulates two proteolytic pathways, caspase-3 and the ubiquitin ligases MAFbx/atrogin-1 and MuRF1 to control muscle protein degradation. These pathways represent therapeutic targets in diseases that cause muscle wasting.
Authors:
Jie Du; William E Mitch
Related Documents :
24735948 - Akt/mtor and c-jun n-terminal kinase (jnk) signaling pathways are required for chrysoti...
8679588 - Evidence for the distinct vanadyl(+4)-dependent activating system for manifesting insul...
11181538 - Targeted protein kinase a and pp-2b regulate insulin secretion through reversible phosp...
21663398 - Geldanamycin analog 17-dmag limits apoptosis in human peripheral blood cells by inhibit...
22815858 - First insight into the kinome of human regulatory t cells.
24094068 - A computational model for overcoming drug resistance using selective dual-inhibitors fo...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in nephrology and hypertension     Volume:  14     ISSN:  1062-4821     ISO Abbreviation:  Curr. Opin. Nephrol. Hypertens.     Publication Date:  2005 Jul 
Date Detail:
Created Date:  2005-06-02     Completed Date:  2005-12-09     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9303753     Medline TA:  Curr Opin Nephrol Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  378-82     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Texas Medical Branch, Galveston, Texas 77555-1064, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Phosphatidylinositol 3-Kinase / metabolism
Animals
Humans
Insulin Receptor Substrate Proteins
Insulin-Like Growth Factor I / metabolism
Muscle Proteins / metabolism*
Muscles / enzymology,  metabolism
Peptide Hydrolases / metabolism
Phosphoproteins / metabolism
Signal Transduction / physiology*
Uremia / metabolism*
Chemical
Reg. No./Substance:
0/IRS1 protein, human; 0/Insulin Receptor Substrate Proteins; 0/Muscle Proteins; 0/Phosphoproteins; 67763-96-6/Insulin-Like Growth Factor I; EC 2.7.1.137/1-Phosphatidylinositol 3-Kinase; EC 3.4.-/Peptide Hydrolases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Elucidating the function of primary cilia by conditional gene inactivation.
Next Document:  Role of hensin in mediating the adaptation of the cortical collecting duct to metabolic acidosis.